Chemical Formula: C15H17N3O2
Chemical Formula C15H17N3O2
Found 22 metabolite its formula value is C15H17N3O2
(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
N-{1-azabicyclo[2.2.2]octan-3-yl}furo[2,3-c]pyridine-5-carboxamide
3-indol-3-ylmethyl-1,6-dimethyl-piperazine-2,5-dione|cyclo(L-Trp-N-methyl-L-Ala-)
3-indol-3-ylmethyl-1,6-dimethyl-piperazine-2,5-dione|cyclo(L-Trp-N-methyl-L-Ala-)
5-[cyclopentyl(prop-2-enyl)amino]-2-nitrobenzonitrile
5-[cyclopentyl(prop-2-enyl)amino]-2-nitrobenzonitrile
ETHYL 5-BENZYL-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE-3-CARBOXYLATE
ETHYL 5-BENZYL-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE-3-CARBOXYLATE
3-AMINO-1,4-DIMETHYL-5H-PYRIDO[4,3-B]INDOLE, ACETATE
3-AMINO-1,4-DIMETHYL-5H-PYRIDO[4,3-B]INDOLE, ACETATE
N-1-azabicyclo[2.2.2]oct-3-ylfuro[2,3-c]pyridine-5-carboxamide
N-1-azabicyclo[2.2.2]oct-3-ylfuro[2,3-c]pyridine-5-carboxamide
N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide
N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide
PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors[1]. PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research[2].
5-(3,5-Dimethyl-1-piperidinyl)-2-(2-furanyl)-4-oxazolecarbonitrile
5-(3,5-Dimethyl-1-piperidinyl)-2-(2-furanyl)-4-oxazolecarbonitrile
5-nitro-N-[(4-propan-2-ylphenyl)methyl]-2-pyridinamine
5-nitro-N-[(4-propan-2-ylphenyl)methyl]-2-pyridinamine
(3s,4r)-3-[(s)-hydroxy(phenyl)methyl]-4-(3h-imidazol-4-yl)-1-methylpyrrolidin-2-one
(3s,4r)-3-[(s)-hydroxy(phenyl)methyl]-4-(3h-imidazol-4-yl)-1-methylpyrrolidin-2-one
3-[hydroxy(phenyl)methyl]-4-(3h-imidazol-4-yl)-1-methylpyrrolidin-2-one
3-[hydroxy(phenyl)methyl]-4-(3h-imidazol-4-yl)-1-methylpyrrolidin-2-one